Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001641172-25-002621
Filing Date
2025-04-03
Accepted
2025-04-03 18:00:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8927
  Complete submission text file 0001641172-25-002621.txt   10562
Mailing Address
Business Address 10590 W OCEAN AIR DR STE 200 SAN DIEGO CA 92130 8583145700
PROEHL GERALD T (Filed by) CIK: 0001279191 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Subject) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92822 | Film No.: 25811276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)